SEC Form 4 · accession 0001555794-15-000005
SCICLONE PHARMACEUTICALS INC · SCLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lan Xie
Officer — VP Finance, China CFO
Period of report
Dec 3, 2015
Accepted (ET)
Dec 7, 2015 · 11:57 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000880771
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 3, 2015 | M | 4,166 | $4.52 | A | 4,166 | D | |
| Common Stock | Dec 3, 2015 | S | 4,166 | $9.50 | D | 0 | D | |
| Common Stock | Dec 3, 2015 | M | 1,875 | $4.53 | A | 1,875 | D | |
| Common Stock | Dec 3, 2015 | S | 1,875 | $9.50 | D | 0 | D | |
| Common Stock | Dec 3, 2015 | M | 8,125 | $5.19 | A | 8,125 | D | |
| Common Stock | Dec 3, 2015 | S | 8,125 | $9.50 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1,F2 | $4.52 | Dec 3, 2015 | M | 4,166 | D | — | Mar 14, 2024 | Common Stock | 4,166 | 24,167 | D |
| Non-Qualified Stock Option (right to buy)F1,F2 | $4.53 | Dec 3, 2015 | M | 1,875 | D | — | Apr 4, 2023 | Common Stock | 1,875 | 5,312 | D |
| Non-Qualified Stock Option (right to buy)F1,F2 | $5.19 | Dec 3, 2015 | M | 8,125 | D | — | Aug 1, 2022 | Common Stock | 8,125 | 12,187 | D |
Explanation of responses
- F1Granted under the Issuer's 2005 Equity Incentive Plan.
- F225% of such shares vest one year from the date of grant and 2.0833% vests each month thereafter, provided that Reporting Person continues to be employed by the Issuer.